1) acute heart failure syndromes
急性心力衰竭症候群
1.
Large amounts of medical and health resources have been devoted to patients with acute heart failure syndromes (AHFS).
急性心力衰竭症候群患者耗费了大量的医疗资源,对其本人、家庭和社会带来了巨大的经济负担。
2) acute heart failure
急性心力衰竭
1.
Clinical observation on recombinant human brain natriuretie peptide(rhBNP) for acute heart failure in 32 cases;
重组人脑利钠肽治疗急性心力衰竭32例临床观察
2.
Clinical characteristics of dogs after open abdominal injury and seawater immersion induced acute heart failure
腹部开放伤合并海水浸泡致犬急性心力衰竭临床特征
3.
Update on drug therapy for acute heart failure
急性心力衰竭药物治疗的研究近况
3) symptomatic heart failure(SHF)
症状性心力衰竭
1.
Method Plasma BNP concentration were measured by a fluorescence immunoassay in normal controls(n=18), asymptomatic heart failure(aSHF) patients (n=21) and symptomatic heart failure(SHF) patients(n=41) .
目的 探讨脑钠素（BNP）对老年性心力衰竭(HF)的诊断和预后评估的价值方法 选取21例老年无症状性心力衰竭（aSHF）患者和41例老年症状性心力衰竭（SHF）患者，将SHF组患者的心功能根据美国纽约心脏病学会（NYHA）分为II级、III级、IV级，另选18例健康老年人作为对照组，采用放射免疫分析法测定各组血浆BNP值。
5) myocardial infarct/heart failure
急性心肌梗塞/心力衰竭
6) acute decompensated heart failure
急性失代偿性心力衰竭
1.
Efficacy and safety of recombinant human brain natriuretic peptide for treating acute decompensated heart failure;
重组人脑利钠肽治疗急性失代偿性心力衰竭的疗效及安全性
2.
Nesiritide:a safe and effective agent for acute decompensated heart failure;
治疗急性失代偿性心力衰竭新药奈西立肽
3.
Objective: This prospective study was to compare the efficacy and safety of intravenous recompine human B-type natriuretic peptide(rhBNP) and nitroglycerin(NTG) in acute decompensated heart failure patients with acute anterior myocardial infarction.
方法:病例选自2003年12月—2004年12月连续收住我科的急性前壁心肌梗死12-24小时内并伴急性失代偿性心力衰竭患者24例。
补充资料：症候群
症候群
即"综合征"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条